Xenobiotic, bile acid, and cholesterol transporters: function and regulation

CD Klaassen, LM Aleksunes - Pharmacological reviews, 2010 - ASPET
Transporters influence the disposition of chemicals within the body by participating in
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …

An update on derivatisation and repurposing of clinical nitrofuran drugs

NH Zuma, J Aucamp, DND David - European Journal of Pharmaceutical …, 2019 - Elsevier
nitrofurans (NFs) have been in clinical use for over 60 years. These affordable drugs are
used for the treatment of a broad spectrum of diseases ranging from urinary tract infections …

The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin

G Merino, JW Jonker, E Wagenaar… - Molecular …, 2005 - ASPET
Nitrofurantoin is a commonly used urinary tract antibiotic prescribed to lactating woman. It is
actively transported into human and rat milk by an unknown mechanism. Our group has …

The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins

AE van Herwaarden, AH Schinkel - Trends in pharmacological sciences, 2006 - cell.com
The breast cancer resistance protein [BCRP (also known as ABCG2)] belongs to the ATP
binding cassette (ABC) family of transmembrane drug transporters. BCRP has a broad …

Drug excretion into breast milk—overview

S Ito, A Lee - Advanced drug delivery reviews, 2003 - Elsevier
Breastfeeding is the optimal form of infant feeding for the first months of an infant's life, and
the majority of healthy women initiate breastfeeding after the birth of their infant. However …

Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction

J Alcorn, X Lu, JA Moscow, PJ McNamara - Journal of Pharmacology and …, 2002 - ASPET
Transporter-mediated processes in the lactating mammary gland may explain the significant
accumulation of certain drugs in breast milk. The purpose of this study was to identify …

On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems

W Wu, K Löbmann, T Rades, H Grohganz - International journal of …, 2018 - Elsevier
Co-amorphous drug delivery systems based on amino acids as co-formers have shown
promising potential to improve the solubility and bioavailability of poorly water-soluble …

Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

M Jani, C Ambrus, R Magnan, KT Jakab, E Beéry… - Archives of …, 2014 - Springer
The discovery and characterization of breast cancer resistance protein (BCRP) as an efflux
transporter conferring multidrug resistance has set off a remarkable trajectory in the …

Drugs in lactation

RHJ Verstegen, S Ito - Journal of Obstetrics and Gynaecology …, 2019 - Wiley Online Library
Although most medications can be taken safely during breastfeeding, potential risks of infant
toxicity do exist because all medications will be excreted into the breast milk to some extent …

Management of multiple sclerosis in the breastfeeding mother

S Almas, J Vance, T Baker… - Multiple sclerosis …, 2016 - Wiley Online Library
Multiple Sclerosis (MS) is an autoimmune neurological disease characterized by
inflammation of the brain and spinal cord. Relapsing‐Remitting MS is characterized by acute …